Acute Exacerbation of Chronic Hepatitis B : Volume 2. Diagnosis and Management / / edited by Qin Ning
| Acute Exacerbation of Chronic Hepatitis B : Volume 2. Diagnosis and Management / / edited by Qin Ning |
| Edizione | [1st ed. 2019.] |
| Pubbl/distr/stampa | Dordrecht : , : Springer Netherlands : , : Imprint : Springer, , 2019 |
| Descrizione fisica | 1 online resource (512 pages) |
| Disciplina | 616.3623 |
| Soggetto topico |
Hepatology
Infectious diseases Cancer - Surgery Infectious Diseases Surgical Oncology |
| ISBN | 94-024-1603-X |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Precipitating factors -- Clinical manifestation, laboratory examination and image -- Complications -- Early monitoring of AECHB and clinical diagnosis of ACLF -- Management -- Antiviral therapy -- Prognosis, prevention and prospective. |
| Record Nr. | UNINA-9910337482203321 |
| Dordrecht : , : Springer Netherlands : , : Imprint : Springer, , 2019 | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Addressing viral hepatitis in people with substance use disorders / / Center for Substance Abuse Treatment (U.S.), issuing body
| Addressing viral hepatitis in people with substance use disorders / / Center for Substance Abuse Treatment (U.S.), issuing body |
| Pubbl/distr/stampa | Rockville, MD : , : U. S. Dept. of Health and Human Services, Substance Abuse and Mental Health Services Administration, Center for Substance Abuse Treatment, , [2011] |
| Descrizione fisica | 1 online resource (132 pages) : illustrations |
| Disciplina | 616.3623 |
| Collana | Treatment improvement protocol (TIP) series |
| Soggetto topico |
Hepatitis, Viral - Treatment
Substance abuse - Complications |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910703320403321 |
| Rockville, MD : , : U. S. Dept. of Health and Human Services, Substance Abuse and Mental Health Services Administration, Center for Substance Abuse Treatment, , [2011] | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Advances in treatment of hepatitis C and B / / edited by Naglaa Allam
| Advances in treatment of hepatitis C and B / / edited by Naglaa Allam |
| Pubbl/distr/stampa | IntechOpen, 2017 |
| Descrizione fisica | 1 online resource (406 pages) |
| Disciplina | 616.3623 |
| Soggetto topico | Hepatitis C |
| Soggetto non controllato |
Medicine
Internal Medicine Infectious Diseases Health Sciences |
| ISBN |
953-51-7347-2
953-51-2994-5 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910317675203321 |
| IntechOpen, 2017 | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Clinical dilemmas in viral liver disease / / edited by, Graham R. Foster, K. Rajender Reddy
| Clinical dilemmas in viral liver disease / / edited by, Graham R. Foster, K. Rajender Reddy |
| Edizione | [Second edition.] |
| Pubbl/distr/stampa | Hoboken, New Jersey ; ; Chichester, West Sussex, England : , : Wiley-Blackwell, , [2020] |
| Descrizione fisica | 1 online resource (271 pages) |
| Disciplina | 616.3623 |
| Soggetto topico | Hepatitis, Viral |
| ISBN |
1-119-53343-0
1-119-53348-1 1-119-53344-9 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910555007203321 |
| Hoboken, New Jersey ; ; Chichester, West Sussex, England : , : Wiley-Blackwell, , [2020] | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Clinical dilemmas in viral liver disease / / edited by, Graham R. Foster, K. Rajender Reddy
| Clinical dilemmas in viral liver disease / / edited by, Graham R. Foster, K. Rajender Reddy |
| Edizione | [Second edition.] |
| Pubbl/distr/stampa | Hoboken, New Jersey ; ; Chichester, West Sussex, England : , : Wiley-Blackwell, , [2020] |
| Descrizione fisica | 1 online resource (271 pages) |
| Disciplina | 616.3623 |
| Soggetto topico | Hepatitis, Viral |
| ISBN |
1-119-53343-0
1-119-53348-1 1-119-53344-9 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910825892403321 |
| Hoboken, New Jersey ; ; Chichester, West Sussex, England : , : Wiley-Blackwell, , [2020] | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Diagnosis and Management of Autoimmune Hepatitis : A Clinical Guide / / edited by Mark W. Russo
| Diagnosis and Management of Autoimmune Hepatitis : A Clinical Guide / / edited by Mark W. Russo |
| Edizione | [1st ed. 2020.] |
| Pubbl/distr/stampa | Cham : , : Springer International Publishing : , : Imprint : Springer, , 2020 |
| Descrizione fisica | 1 online resource (X, 166 p. 35 illus., 33 illus. in color.) |
| Disciplina | 616.3623 |
| Soggetto topico |
Gastroenterology
Hepatology |
| ISBN | 3-030-33628-X |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Epidemiology and Burden of Disease -- The Pathogenesis of Autoimmune Liver Diseases -- Clinical Presentation and Diagnosis -- The Pathology of Autoimmune Hepatitis -- Treating the Adult Patient-First Line Therapy -- Treating the Adult Patient: Alternative Drug Therapies -- The Approach to the Pediatric Patient -- Autoimmune Hepatitis and Pregnancy -- Liver Transplantation for Autoimmune Hepatitis -- Autoimmune Overlap Syndromes -- Drug Induced Liver Injury with Autoimmune Features. |
| Record Nr. | UNINA-9910383838303321 |
| Cham : , : Springer International Publishing : , : Imprint : Springer, , 2020 | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Epatite C : l'epidemia silenziosa : una guida chiara e dettagliata per malati, familiari e medici / Ivan Gardini ; con la collaborazione di Claudio Puoti
| Epatite C : l'epidemia silenziosa : una guida chiara e dettagliata per malati, familiari e medici / Ivan Gardini ; con la collaborazione di Claudio Puoti |
| Autore | GARDINI, Ivan |
| Pubbl/distr/stampa | Milano : F. Angeli, 1999 |
| Descrizione fisica | 254 p. ; 23 cm. |
| Disciplina | 616.3623 |
| Collana | Self-help |
| Soggetto topico | Epatite virale |
| ISBN | 88-464-2887-0 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | ita |
| Record Nr. | UNISA-990000523420203316 |
GARDINI, Ivan
|
||
| Milano : F. Angeli, 1999 | ||
| Lo trovi qui: Univ. di Salerno | ||
| ||
Guidelines for the screening, care and treatment of persons with hepatitis C infection : April 14 / / World Health Organization
| Guidelines for the screening, care and treatment of persons with hepatitis C infection : April 14 / / World Health Organization |
| Pubbl/distr/stampa | Geneva, Switzerland : , : World Health Organization, , [2014] |
| Descrizione fisica | 1 online resource (121 p.) |
| Disciplina | 616.3623 |
| Soggetto topico | Hepatitis C - Diagnosis |
| ISBN | 92-4-069390-4 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Cover; CONTENTS; ACKNOWLEDGEMENTS; ABBREVIATIONS AND ACRONYMS; GLOSSARY OF TERMS; EXECUTIVE SUMMARY; 1. SCOPE AND OBJECTIVES; 2. BACKGROUND; 2.1 Epidemiology of hepatitis C; 2.1.1 Routes of transmission; 2.1.2 Coinfections; 2.2 Hepatitis C virus; 2.3 Natural history of HCV infection; 2.4 Prevention of HCV infection; 2.5 Screening for HCV infection; 2.6 Care of patients with HCV infection; 2.7 Treatment of patients with HCV infection; 2.8 Cost-effectiveness of treatment; 3. GUIDING PRINCIPLES; 3.1 Human rights; 3.2 Access to health care; 3.3 Service provision; 3.4 Integrated health care
4. METHODS5. RECOMMENDATIONS ON SCREENING; 5.1 Screening to identify persons with HCV infection; 5.2 When to confirm a diagnosis of chronic HCV infection; 6. RECOMMENDATIONS ON CARE OF PEOPLE INFECTED WITH HCV; 6.1 Screening for alcohol use and counselling to reduce moderate and high levels of alcohol intake; 6.2 Assessing the degree of liver fibrosis and cirrhosis; 7. RECOMMENDATIONS ON TREATMENT; 7.1 Assessment for HCV treatment; 7.2 Treatment with pegylated interferon and ribavirin; 7.3 Treatment with telaprevir or boceprevir 7.4 Introduction to recommendations concerning sofosbuvir and simeprevir7.5 Treatment with sofosbuvir; 7.6 Treatment with simeprevir; 8. CLINICAL CONSIDERATIONS; 8.1 Monitoring for toxicity; 8.2 Dose modification; 8.3 Monitoring for efficacy; 9. SPECIAL CONSIDERATIONS FOR SPECIFIC POPULATIONS; 9.1 People who inject drugs; 9.2 Persons with HIV and HCV coinfection; 9.3 Children and adolescents; 9.4 Persons with liver cirrhosis; 9.5 Persons with HBV and TB coinfection; 9.6 Persons with renal impairment; 10. OPERATIONAL AND IMPLEMENTATION ISSUES; 10.1 Service planning; 10.2 Service delivery 10.3 Future considerations10.4 Dissemination, monitoring and implementation of the Guidelines; 11. REFERENCES |
| Record Nr. | UNINA-9910796927103321 |
| Geneva, Switzerland : , : World Health Organization, , [2014] | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Guidelines for the screening, care and treatment of persons with hepatitis C infection : April 14 / / World Health Organization
| Guidelines for the screening, care and treatment of persons with hepatitis C infection : April 14 / / World Health Organization |
| Pubbl/distr/stampa | Geneva, Switzerland : , : World Health Organization, , [2014] |
| Descrizione fisica | 1 online resource (121 p.) |
| Disciplina | 616.3623 |
| Soggetto topico | Hepatitis C - Diagnosis |
| ISBN | 92-4-069390-4 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Cover; CONTENTS; ACKNOWLEDGEMENTS; ABBREVIATIONS AND ACRONYMS; GLOSSARY OF TERMS; EXECUTIVE SUMMARY; 1. SCOPE AND OBJECTIVES; 2. BACKGROUND; 2.1 Epidemiology of hepatitis C; 2.1.1 Routes of transmission; 2.1.2 Coinfections; 2.2 Hepatitis C virus; 2.3 Natural history of HCV infection; 2.4 Prevention of HCV infection; 2.5 Screening for HCV infection; 2.6 Care of patients with HCV infection; 2.7 Treatment of patients with HCV infection; 2.8 Cost-effectiveness of treatment; 3. GUIDING PRINCIPLES; 3.1 Human rights; 3.2 Access to health care; 3.3 Service provision; 3.4 Integrated health care
4. METHODS5. RECOMMENDATIONS ON SCREENING; 5.1 Screening to identify persons with HCV infection; 5.2 When to confirm a diagnosis of chronic HCV infection; 6. RECOMMENDATIONS ON CARE OF PEOPLE INFECTED WITH HCV; 6.1 Screening for alcohol use and counselling to reduce moderate and high levels of alcohol intake; 6.2 Assessing the degree of liver fibrosis and cirrhosis; 7. RECOMMENDATIONS ON TREATMENT; 7.1 Assessment for HCV treatment; 7.2 Treatment with pegylated interferon and ribavirin; 7.3 Treatment with telaprevir or boceprevir 7.4 Introduction to recommendations concerning sofosbuvir and simeprevir7.5 Treatment with sofosbuvir; 7.6 Treatment with simeprevir; 8. CLINICAL CONSIDERATIONS; 8.1 Monitoring for toxicity; 8.2 Dose modification; 8.3 Monitoring for efficacy; 9. SPECIAL CONSIDERATIONS FOR SPECIFIC POPULATIONS; 9.1 People who inject drugs; 9.2 Persons with HIV and HCV coinfection; 9.3 Children and adolescents; 9.4 Persons with liver cirrhosis; 9.5 Persons with HBV and TB coinfection; 9.6 Persons with renal impairment; 10. OPERATIONAL AND IMPLEMENTATION ISSUES; 10.1 Service planning; 10.2 Service delivery 10.3 Future considerations10.4 Dissemination, monitoring and implementation of the Guidelines; 11. REFERENCES |
| Record Nr. | UNINA-9910815061603321 |
| Geneva, Switzerland : , : World Health Organization, , [2014] | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
HCV: The Journey from Discovery to a Cure : Volume II / / edited by Michael J. Sofia
| HCV: The Journey from Discovery to a Cure : Volume II / / edited by Michael J. Sofia |
| Edizione | [1st ed. 2019.] |
| Pubbl/distr/stampa | Cham : , : Springer International Publishing : , : Imprint : Springer, , 2019 |
| Descrizione fisica | 1 online resource (VIII, 500 p. 50 illus., 20 illus. in color.) |
| Disciplina |
616.362306
616.3623 |
| Collana | Topics in Medicinal Chemistry |
| Soggetto topico |
Pharmaceutical chemistry
Virology Clinical biochemistry Bioorganic chemistry Pharmaceutical technology Medicinal Chemistry Medical Biochemistry Bioorganic Chemistry Pharmaceutical Sciences/Technology |
| ISBN | 3-030-28400-X |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | NS5A as a target for HCV Drug Discovery -- The Discovery and Development of Daclatasvir: An Inhibitor of the Hepatitis C Virus NS5A Replication Complex -- The Discovery of Ledipasvir (GS-5885): The Potent Once-Daily Oral HCV NS5A Inhibitor in the Single-Tablet Regimen Harvoni® -- The Discovery of Velpatasvir (GS-5816): The Potent Pan-Genotypic Once-Daily Oral HCV NS5A Inhibitor in the Single-Tablet Regimens Epclusa® and Vosevi® -- Discovery of Elbasvir -- HCV NS5A as an Antiviral Therapeutic Target: From Validation to the Discovery and Development of Ombitasvir and Pibrentasvir as Components of IFN-Sparing HCV Curative Treatments -- Evolution of HCV NS4B Inhibitors -- The Evolution of Clinical Trials for Hepatitis C -- The Clinical Development of Ledipasvir/Sofosbuvir (LDV/SOF, Harvoni®) -- The Clinical Development of Sofosbuvir/Velpatasvir (SOF/VEL, Epclusa®) -- The Clinical Development of Sofosbuvir/Velpatasvir/Voxilaprevir (SOF/VEL/VOX, Vosevi®) -- Clinical Development of Viekira Pak to Mavyret -- Development of ZEPATIER® -- Real world effectiveness of DAA therapies -- The Benefit of Direct-Acting Antiviral HCV Cure Therapies -- Cure and Control: What Will It Take to Eliminate HCV? -- Perspectives on HCV Cure. |
| Record Nr. | UNINA-9910377840203321 |
| Cham : , : Springer International Publishing : , : Imprint : Springer, , 2019 | ||
| Lo trovi qui: Univ. Federico II | ||
| ||